The localization of a protein is intrinsically linked to its role in the structural and functional organization of the cell. Advances in transgenic technology have streamlined the use of protein localization as a function discovery tool. Here we review the use of large genomic DNA constructs such as bacterial artificial chromosomes as a transgenic platform for systematic tag-based protein function exploration.
Introduction
For decades, immunostaining with protein specific antibodies has provided a reliable method for protein localization and antibodies are now available for a large number of proteins. Over the last 10 years the Human Protein Atlas program (HPA) has generated a collection of over 50,000 polyclonal antibodies targeting 19,100 (95%) human protein-coding genes [1] . Many of them have already been used to generate validated protein expression profiles and to systematically map the subcellular localization in fixed cells [2] [3] [4] [5] . Antibodies are a versatile affinity reagent and can be applied in any cell line or tissue from the target species and even across species when the epitope is conserved. However, antibodies have a number of known limitations that have to be taken into account in every experiment. Although in vivo localization approaches based on fluorescently labeled single chain Fab fragments (scFabs) or camelid single chain antibodies (often referred as nanobodies) is possible [6] [7] [8] , the vast majority of the available antibodies require cell fixation and permeabilization, which can cause cell shrinkage or leakage of endogenous components [9, 10] . Antibodies are also prone to cross-reactivity and often cannot discriminate between protein isoforms that have different subcellular localizations [11] .
The ability to observe protein localization in vivo can often reveal functionally relevant dynamics that cannot be inferred from immunostaining [12] [13] [14] . Since the first use of the Aequorea victoria green fluorescent protein (GFP) over 20 years ago [15] a large array of fluorescent proteins with various properties and methods for expression of fluorescently tagged proteins (Table 1) have been developed [16, 17] . The cloning of cDNA derived open reading frames (ORFs) into standard expression vectors was one of the early approaches for systematic tag-based protein localization mapping [18] . A proteome-scale localization map was generated in budding yeast through the systematic cloning of ORFs into plasmid vectors for inducible overexpression of V5 tagged proteins, followed by immunostaining with an anti-V5 antibody [19] and similar approaches have been used in other systems [20] [21] [22] . Due to its simplicity this approach remains very popular and large scale ORF resources are now available for many commonly used model systems, typically in vector formats that allow the easy shuffling to expression vectors containing fluorescent or epitope tags [20, [23] [24] [25] [26] . However, the heterologous promoters and 3 0 regulatory elements often used with these type of vectors do not reflect the endogenous expression levels of most proteins and can disturb cellular functions. Since certain diseases can be caused by abnormally high protein levels [27] , cDNA transgenes have been used in systematic screens for such phenotypes, for example in an activator screen for the antioxidant response element in human cells [28] . In addition, overexpression may lead to saturation of the specific binding sites of a protein leading to lead to mislocalization and/or obscuring of the normal localization pattern.
The most reliable way to ensure endogenous regulatory control of the tagged protein expression is the direct targeting of the genomic locus. Two major strategies, the transposon or viral vector mediated random insertion and the homology directed precise targeting, have been developed in parallel with their own advantages and limitations. The main advantage of the random approach is the ability to rapidly generate and map a large number of insertions. The tag can be either inserted directly or through an exchange of a previously inserted gene trap cassette by recombinase mediated cassette exchange (RMCE) [19, [29] [30] [31] [32] [33] [34] [35] . Some of the technical limitations of this approach, including a insertion bias towards a particular sequence content, were mostly overcome with later generations of these vectors. However, all random approaches suffer from diminishing returns, where the number of repeatedly hit genes grows and the number of new genes rapidly declines, and only a fraction of the inserts can result in a functional tagged protein. Until recently, homology directed repair (HDR) was only practical in a small number of model systems and has only been used for proteome-scale localization studies in a few species including Saccharomyces cerevisiae [36] . The discovery of the CRISPR/Cas technology has dramatically increased the efficiency of gene targeting in systems where such tools were already available and has made genome engineering feasible in species that so far appeared resistant to this approach. However, a number of technical and logistic challenges still need to be addressed before systematic genome-wide HDR targeting based tagging in mammalian systems becomes reality.
Genomic DNA (gDNA) transgenes provide an alternative that combines the ease and efficiency of cDNA transgenics with preservation of the endogenous regulatory expression control comparable with gene targeting. In this review, we explore various applications of the gDNA transgene approach and compare it to other methods for protein localization.
gDNA transgenesis as platform for protein function exploration

Methods for gDNA transgene engineering
The first attempts to use gDNA for large scale GFP tagging was cloning of random fragments of the fission yeast genome into expression vectors, resulting in one of the early protein localization maps [37] . This approach is not practical for metazoan genes, which can be orders of magnitude bigger than in yeast. However, large insert gDNA libraries of bacterial artificial chromosomes (BACs), P1-derived artificial chromosomes (PACs), or yeast artificial chromosomes (YACs) that can cover most genes with their endogenous cis regulatory context are available for many model systems. When used as transgenes, these clones typically exhibit near-physiological levels and patterns of gene expression and are routinely used in mapping mutations by complementation [38] . YACs can be engineered in vivo by homologous recombination in yeast [39, 40] and the development of efficient methods for homologous recombination mediated engineering in Escherichia coli [41, 42] made it possible to apply this approach to the easier to handle fosmid/BAC/PAC constructs. Most E. coli cloning hosts exhibit very low levels of spontaneous recombination, which ensures a stable maintenance of large and repetitive clones. A simple two-component recombination system, consisting of an exonuclease and a strand annealing protein from the phage lambda or related phages, is sufficient for an efficient and precise homologous recombination in E. coli with only 30-50 bp of homology [41, 43, 44] . As recombineering is independent of the availability of restriction sites and can be used to insert, delete, change or retrieve any sequence of interest to and from any DNA that can be propagated in E. coli it was soon adapted to a wide spectrum of applications. BAC recombineering provided an efficient way to engineer point mutations, create translational or transcriptional reporters and targeting constructs for genome editing [45] [46] [47] [48] for almost any gene of interest in a range of model organisms (mammals: [49] [50] [51] ; fly: [52, 53] ; worm: [54] [55] [56] [57] ). With recombineering, the tag coding sequence can be inserted into the gene of interest at the N-or the C-terminus or at any internal position of choice, allowing the tagging of specific splice forms. The tag is typically inserted as a cassette with a selectable marker, which can be removed by site-specific excision through recombinases like Cre or Flp. Methods have been developed to allow the easy exchange of the tag in the transgene by either homologous recombination [45] or RMCE [58] .
System-scale gDNA transgenesis
The high recombineering efficiency, near absence of unintended recombination background and the ease of handling E. coli in liquid culture lead to the development of high throughput pipelines for multi-step recombineering in a 96 well plate format for parallel engineering of a large number of constructs in Caenorhabditis elegans [59] , mammals [60] and Drosophila [52, 53, 61] (Fig. 1) . Using this approach a C. elegans library of 14637 tagged fosmid transgenes was constructed, which enabled the in vivo localization or affinity purification of 73% of the proteome [54] . The fosmid collection was used to create over 580 transgenic C. elegans lines. All constructs, lines and associated localization patterns are accessible at https://transgeneome.mpi-cbg.de. Since the release of the C. elegans TrangeneOme resource, 2806 constructs have been distributed to labs around the world in a community-wide effort to generate a proteome scale resource of tagged transgenic lines. Using a similar approach [52, 53, 61] a collection covering approximately 10000 Drosophila genes was recently created, from which transgenic lines for 826 genes were already established. The 'tagged FlyTransgeneOme' (fTRG) lines are available at the VDRC stock centre (http://stockcenter.vdrc.at) [61] . Systematic BAC transgenesis in mammalian cell lines [60] has led to the generation of over 6000 BAC-tagged cell lines, including HeLa, U2OS, mouse embryonic stem cells and MDCK (http://hymanlab.mpi-cbg.de/ bac). Over 5800 lines have been sent to 160 labs in 26 countries. Their applications spanned from the investigation of small amounts of different lines [62, 63] The receptor protein Bmpr1a localizes to the plasma membrane; as one of the core subunits of the SMN complex, SMN1 forms granules in the cytoplasm corresponding to the cytosolic assembly of small nuclear ribonucleoprotein particles (snRNPs) by the SMN complex and subnuclear bodies consistent with the final maturation of the snRNPs within Cajal bodies of the nucleus [93] ; Small dots are formed as well by Pml, presumably Pml-bodies; Utp3 localizes specifically to the nucleolus; the kinetochore protein Cenpq localizes where it is required for proper kinetochore function and mitotic progression [94] ; while the nuclear pore complex protein Nup-107 localizes to the nuclear membrane.
(C) C. elegans. GFP fluorescence is shown. Actinin-1 (Atn-1) and Profilin-2 (Pfn-2) localize to muscles, while the nuclear pore complex protein Npp-1 can be found at the nuclear envelope. Gei-11 is a transcription factor that specifically regulates the expression of the snRNA genes, which are clustered on chromosome IV, resulting in specific punctate subnuclear localization; Syp-1 is a member of the synaptonemal complex; Cnd-1 is the worm NeuroD ortholog.; Images taken (with permission) from: http://tomancak-srv1.mpi-cbg.de/DOT/main.html, http://hymanlab.mpi-cbg.de/bac/login.jsp, https://transgeneome.mpi-cbg.de.
affinity-purification tag (LAP-tag) for investigating protein complexes in mitosis. The exploration of their localization and physical interaction partners led to the discovery of complexes essential for spindle assembly and chromosome segregation [50] . Maliga et al. used BAC transgenics to explore the function of 243 mouse and human motor proteins [51] .
Advantages and known limitations of the gDNA transgene approach
The main advantage of the gDNA/BAC approach is the high efficiency of engineering and transgenesis, which can reach the 80-90% range in mammalian tissue culture applications [60] . Combined with the low costs of this approach, gDNA transgenesis provides a way to quickly explore the function for large sets of genes. Due to their large size, BACs appear more resistant to position effects than smaller plasmid transgenes, but are prone to fragmentation and rearrangement during transgenesis and independent lines should be obtained and compared to verify the observed patterns. The integrity and localization of the BAC can be determined by targeted locus amplification (TLA) [65] . This issue can be overcome through various techniques that ensure intact, single copy transgene integration. In Drosophila, the efficient phiC31 integrase mediated insertion of a fosmid/BAC transgene at a pre-defined genomic position is reliable and a large number of insertion sites are available [35, 66, 67] . In mammalian cells the PiggyBac and the Sleeping Beauty transposons have been shown to efficiently jump into the genome with intact BAC sized cargo, typically as a single copy [68, 69] . A similar approach using the Drosophila Mauritania transposon Mos1 works efficiently in C. elegans [70] . Recently, an approach was developed that utilizes programmable nucleases like Zn fingers, TALENs or Cas9 to induce NHEJ mediated insertion of transgenes at any point of interest in the target genome that appears suitable for large inserts [71] .
Typically, gDNA transgenes do not suffer from the strong overexpression common for cDNA transgenes [11] , however, they are still present in addition to the endogenous alleles. As many proteins tend to have similar expression levels as their binding partners, in some cases even a slight overexpression can perturb this balance causing mislocalisation and abnormal phenotypes [72] . On the other hand, a slight overexpression would in most cases be tolerated by the cell and may even be beneficial for the localization of proteins expressed at levels close to the detection limit for in vivo imaging.
A known limitation of any tagging approach is the potential for the tag to interfere with the normal protein function by altering its charge and size or by affecting protein folding, degradation, the binding of interaction partners etc. However, improvements in tag design, the use of flexible linkers and rational design of the tag insertion points (to avoid interference with signaling peptides or catalytic domains for example) have helped to minimize this problem, and systematic comparisons with immunofluorescent labeling or rescue of mutant phenotypes [61] with tagged transgenes [11] show that this is a minor issue that can be controlled for and typically overcome. This is particularly straightforward with gDNA transgene recombineering as there are practically no restrictions on the tag insertion position.
Applications of BAC transgenics beyond localization
Once generated, the BAC transgenes can be used with any cell line or a model organism that can be efficiently transfected and have many additional applications (Fig. 2) . A large variety of tagging cassettes are now available that reflect the specifics of the model organism and the biological question they are used to address. Most tagging cassettes use a combination of fluorescent and affinity epitopes and can be used for both localization and purification [45, 52, 60, 73] . Earlier affinity purification protocols favored a multi-step approach to ensure highly pure complexes, but with the development of stable isotope labeling (SILAC) or label-free quantitative mass-spec methods, a single step purification is often sufficient and can preserve weaker integrations that might otherwise be missed [74] [75] [76] . Tag specific purification makes other affinity applications such as chromatin immunopurification (ChIP) [45, 60, [77] [78] [79] [80] , photoactivatable-ribonucleoside-enh anced crosslinking and immunoprecipitation (PAR-Clip) [81] more comparable and reliable as it removes variability in non-specific antibody interaction.
Beyond the simple tagging with the commonly used fluorescent proteins and affinity epitopes the tagging cassettes can add useful properties that cannot be achieved with the antibody based techniques. For example, poly-cistronic expression cassettes have been developed for various species including mammalian cells, C. elegans [55, 82] and Drosophila [83, 84] , which can be used to drive the expression of a selection marker or to facilitate the identification of the expressing cell by targeting a fluorescent reporter to a specific and easy to identify compartment like the cell nucleus [55] . Identifying the expressing cell in complex tissues with antibody staining can be non-trivial, especially for highly polarized and irregularly shaped cells like neurons where a protein can localize far away from the cell body. The expression of multiple proteins from the same mRNA can be facilitated by the use of viral 2A and internal ribosomal entry site (IRES) sequences. The 2A sequence induces a ''ribosomal skip" during translation, which results in a release of the first peptide without interrupting translation of the Subcloning by recombineering is efficient as homology arms of any designed length can be subcloned. It is not affected by the specific sequence composition (high/low GC content) as with other PCR-based methods.
following peptide [85] . IRES sequences work by causing additional initiation of translation from the same transcript. In C. elegans a bi-cistronic expression has been achieved using the trans-splice leader 2 (SL2) sequence, which results in the expression of 2 mRNAs [55] . As the expression levels may vary depending on the inter-cistronic region used, the viral 2A peptides should be preferred over the IRES [86] or SL2 [55] sequences when nearstoichiometric expression levels are required [87] . BACs and fosmids can be used to explore the changes in the localization dynamics of gene variants (SNPs, insertions, deletions) that can be easily introduced into the transgene by recombineering. Since the endogenous gene locus is not disrupted, the function of gene mutations that would otherwise be lethal could also be studied. RNA interference against the endogenous protein in combination with an RNAi-resistant fusion protein can be used to knock down the endogenous protein for structure-function studies. This approach can be used in reverse to confirm the specificity of an RNAi experiment in human cells using RNAi-resistant BACs carrying the orthologous mouse gene [88] . A similar strategy can be applied to make a BAC-transgene resistant to Cas9 cleavage of the endogenous locus.
Summary and perspective
In the last two decades, we have seen an enormous progress in our ability to understand protein function though localization and many tools and resources have made these studies much more straightforward and routine. So far the only comprehensive localization pattern resources in model organisms more complex than yeast are based on antibody staining, which limits our ability to understand protein localization dynamics in vivo. The large-scale BAC transgenesis applications demonstrate that systems scale protein tagging is feasible and these efforts will likely accelerate with the arrival of the CRISPRS/Cas technology for direct genome editing, allowing the in vivo interrogation of any protein of interest at near-physiological expression levels. In recent years new techniques for organ-like induced pluripotent stems cells [89] [90] [91] and organoids [92] have made it possible to address a number of experimental questions in human cells that would have previously required the use of potentially less disease relevant model organisms. In combination with modern imaging techniques like SPIM that allow for long-term live imaging of mesoscale samples with minimal photodamage, these tools would allow us to understand the restructuring of the cellular proteome in development and disease, and to assign functions to thousands of previously uncharacterized human proteins.
